Australia - English - Department of Health (Therapeutic Goods Administration)

recordati rare diseases australia pty ltd - betaine, quantity: 1 g/g - powder, oral - excipient ingredients: - as an adjunct in the treatment of homocystinuria.

United States - English - NLM (National Library of Medicine)

jazz pharmaceuticals, inc. - betaine, anhydrous (unii: 3scv180c9w) (betaine, anhydrous - unii:3scv180c9w) - powder, for solution - 180 g in 1 g - cystadane (betaine anhydrous for oral solution) is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood levels. included within the category of homocystinuria are deficiencies or defects in: - cystathionine beta-synthase (cbs), - 5,10-methylenetetrahydrofolate reductase (mthfr), - cobalamin cofactor metabolism (cbl ). patient response to cystadane can be monitored by homocysteine plasma levels (see dosage and administration). response usually occurs within a week and steady state within a month. cystadane has been administered concomitantly with vitamin b6 (pyridoxine), vitamin b12 (cobalamin), and folate.

Canada - English - Health Canada

rheingold food international ltd. - betaine hydrochloride; pepsin - tablet - 324mg; 135mg - betaine hydrochloride 324mg; pepsin 135mg - digestants

United States - English - NLM (National Library of Medicine)

gowoonsesang cosmetics co., ltd. - betaine (unii: 3scv180c9w) (betaine - unii:3scv180c9w) - betaine 0.5 g in 100 ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - betaine - oral solution - 500mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - betaine - oral tablet - 500mg

Israel - English - Ministry of Health

medison pharma ltd - betaine anhydrous - powder for solution - betaine anhydrous 1 g/g - betaine - treatment of homocystinuria.

Australia - English - Department of Health (Therapeutic Goods Administration)

neolife international pty ltd - betaine hydrochloride, quantity: 275 mg; pepsin, quantity: 130 mg; papain, quantity: 10 mg; beta vulgaris, quantity: 5 mg; rhubarb, quantity: 5 mg; pectin, quantity: 3 mg; liquorice, quantity: 2 mg - tablet, film coated - excipient ingredients: cellulose; colloidal anhydrous silica; magnesium stearate; calcium hydrogen phosphate dihydrate; guar gum; carob gum - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

marlborough pharmaceuticals ltd - cloral betaine - oral tablet - 707mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - cloral betaine - oral tablet - 707mg